|Bid||67.65 x 1000|
|Ask||67.67 x 800|
|Day's range||66.40 - 67.67|
|52-week range||60.57 - 94.87|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||28.85|
|Earnings date||29 Jan 2024 - 02 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||79.38|
While Edwards Lifesciences Corporation ( NYSE:EW ) shareholders are probably generally happy, the stock hasn't had...
In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing […]
Ozempic, Novo Nordisk's (NYSE: NVO) blockbuster drug for type 2 diabetes, is having all sorts of unexpected impacts on the healthcare sector. With the help of similar medicines made by Eli Lilly (NYSE: LLY), and expanded labels that allow the two companies to market formulations of those products for obesity, everyone from big pharmas to medical device manufacturers is trying to plan for a future in which it's easier for patients to lose weight.